---
$id: https://graph.org.ai/products/commodity/51392211
$type: Product
source: UNSPSC
code: "51392211"
title: "Mivazerol or piroximone"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mivazerol or piroximone

**UNSPSC Code**: 51392211
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5P1SSA8KD, chemically known as alpha-imidazol-4-yl-2,3-cresotamide but generally known as mivazerol, which bears US NIH Compound Identifier 60784. European Medicines Agency schedules Mivazerol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09015MIG. The term MIVAZEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). Mivazerol or piroximone bears US NLM identifiers UMLS ID C0071150 and NCI Concept Code C90921. SMILES: CCC1=C(NC(=O)N1)C(=O)C2=CC=NC=C2.

